Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07907575
NA

The Role of ERBT Plus Adjuvant Intravesical Induction and Maintenance Chemotherapy for Intermediate-Risk NMIBC

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

This is a prospective, multi-centre randomised trial comparing between ERBT plus 1-year of Ad-MMC, versus ERBT alone, in treating intermediate-risk NMIBC.

Official title: A Randomised Trial Investigating The Role of En Bloc Resection of Bladder Tumour Plus Adjuvant Intravesical Induction and Maintenance Chemotherapy for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

440

Start Date

2027-01-01

Completion Date

2030-03-31

Last Updated

2026-10-30

Healthy Volunteers

No

Conditions

Interventions

DRUG

ERBT and Adjuvant MMC Therapy

Subject will receive 1-year of Ad-MMC after ERBT

PROCEDURE

ERBT

Subject will undergo ERBT

Locations (2)

Prince of Wales Hospital

Hong Kong, Hong Kong

Prince of Wales Hospital

Shatin, Hong Kong